ClinicalTrials.Veeva

Menu
D

DermResearchCenter of New York | Rafal Center for Dermatology and Cosmetic Surgery

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3009104
Baricitinib
IDP-107
Upadacitinib
Ritlecitinib
M518101
Lebrikizumab
imiquimod

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

The purpose of this study is to learn about the safety and effects of the study medicine ritlecitinib for the possible treatment of nonsegmental viti...

Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo

Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to...

Invitation-only
Vitiligo
Drug: Upadacitinib
Drug: Placebo

Trial sponsors

Lilly logo
AbbVie logo
D
D
Genentech logo
G
Maruho logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems